Real-time enrollment status for this schizophrenia clinical trial
Current Status
Recruiting
Checked: August 31, 2026 at 4:13 PM UTC
| NCT Number | NCT07680946 |
| Recruiting Status | Recruiting |
| Condition | Schizophrenia |
| Phase | PHASE2 |
| Target Enrollment | 60 participants |
| Active Locations | 2 sites in the US |
| Sponsor | TG Therapeutics, Inc. |
| Last Updated on CT.gov | August 26, 2026 (5 days ago) |
As of August 31, 2026: Clinical trial NCT07680946 is currently recruiting participants. This phase2 study for schizophrenia is actively seeking new participants at 2 locations across the United States. The study is sponsored by TG Therapeutics, Inc.. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT07680946 is actively recruiting participants as of August 31, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 2 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT07680946 was last updated 5 days ago (August 26, 2026). HelloStudys verifies this status automatically.